Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 2025

Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape.

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaría Antonietta BarbieriVBVera BattiniCCCarla Carnovale

Discussion

Loading...

Member takes

Overview

Review highlights AI tools for signal management in pharmacovigilance, indicating regulatory challenges remain.

Key Points

  • AI tools enhance signal management in pharmacovigilance, improving speed and accuracy of decision-making.
  • Regulatory landscape for AI in pharmacovigilance is complex and varies across regions.
  • International collaboration is needed to harmonize regulatory frameworks in drug safety.
  • Ongoing challenges in AI implementation must be addressed to ensure ethical drug safety and improve healthcare outcomes.

Cite This Study

Barbieri et al. (2025) studied this question.

synapsesocial.com/papers/689dfe97d61984b91e13c234https://doi.org/10.1080/14740338.2025.2545926
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration2025 · 40 citations
  2. 2Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool2025 · 26 citations
  3. 3Pharmacovigilance: Emerging trends, ongoing challenges, AI and future outlook in pharmacovigilance2025 · 2 citations
  4. 4Optimizing Drug Safety and Compliance in Real-Time by Using Block chain and Artificial Intelligence for Integrated Clinical Data Management and Pharmacovigilance2025
  5. 5Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights2025 · 8 citations